Oripavine Oxidation to 14-Hydroxymorphinone
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing opiates such as oxymorphone, naltrexone, and buprenorphine from thebaine or morphine are complex and inefficient, requiring multiple steps and intermediate compounds, whereas oripavine offers a more direct and economical conversion pathway.
Innovation Solution
Oripavine is oxidized with oxidizing agents like peroxy acids to produce 14-hydroxymorphinone, which is then reduced to obtain oxymorphone, and further processed to produce naltrexone and buprenorphine, utilizing catalytic hydrogenation and purification methods to achieve high yields and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional methods using thebaine or morphine are used to synthesize opiates, then the synthesis process requires multiple steps and intermediate compounds, but this increases process complexity and reduces efficiency
Solution Approach 1:
The patent extracts the essential functional groups from oripavine that are needed for the target opiate structures, eliminating unnecessary intermediate steps. By directly targeting the key functional transformations (oxidation at C14, reduction of ketone, formation of cyclopropane ring), the process removes redundant intermediate compounds and steps while maintaining the core synthetic objectives.
Solution Approach 2:
The synthesis process is segmented into distinct functional transformations: oxidation of oripavine to 14-hydroxymorphinone, reduction to the corresponding alcohol, and cyclization to form the cyclopropane ring. This segmentation allows each step to be optimized independently and simplifies the overall process by breaking down the complex transformation into manageable, high-yield steps.
2Loss of substance
If traditional multi-step synthesis methods are used, then more intermediate compounds are required, but this increases the formation of by-products and reduces yield
Solution Approach 1:
The patent maintains continuous useful action by designing a streamlined sequence where each step builds directly on the previous one without unnecessary interruptions. The oxidation, reduction, and cyclization steps occur in a continuous flow, minimizing the accumulation of by-products and maximizing the conversion of starting material to desired product at each stage.
Solution Approach 2:
The patent utilizes parameter changes in reaction conditions (temperature, pH, reagent concentration) to optimize each transformation step. By carefully controlling these parameters, the process achieves high yields and minimizes by-product formation, transforming the synthesis from a multi-step low-yield process to an efficient high-yield sequence.
3Loss of time
If conventional synthesis routes are used, then the conversion process is less direct, but this increases the time required for synthesis
Solution Approach 1:
Instead of following the conventional reverse path from thebaine/morphine to oripavine and then to the target opiates, the patent inverts the approach by starting with oripavine and directly transforming it into the desired products. This inversion creates a more direct pathway that reduces synthesis time while maintaining structural fidelity.
Solution Approach 2:
The patent performs preliminary action by pre-organizing the molecular structure of oripavine with functional groups positioned for optimal transformation. The oxidation at C14, the ketone reduction, and the cyclopropane formation are prepared in advance within the oripavine structure, allowing rapid conversion to the target opiates without requiring time-consuming intermediate steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for efficient conversion of oripavine to these opiates with high yields (>90%) and minimizes the formation of by-products, providing a more economical and streamlined synthesis process compared to traditional methods.
Implementation Method 1
Oripavine is oxidized with oxidizing agents like peroxy acids to produce 14-hydroxymorphinone
Implementation Method 2
which is then reduced to obtain oxymorphone
Implementation Method 3
further processed to produce naltrexone and buprenorphine, utilizing catalytic hydrogenation
Data Source
AI summary
Methods are provided which include converting oripavine to other opiates, including converting oripavine to naltrexone, buprenorphine, 14-hydroxymorphinone and/or converting 14-hydroxymorphinone to oxymorphone. Purification and salt formation are optionally included.